Drug intelligence / Profile preview

13C5-calcium-L-leucovorin

Development stage
Unknown
Lead developer
SickKids
Modality
Small Molecules
Administration
Oral
01

Overview

13C5-calcium-L-leucovorin is a stable-isotope-labeled form of calcium L-leucovorin (folinic acid) containing five carbon-13 atoms. It is primarily utilized as a metabolic tracer in clinical research to study folate absorption, bioavailability, and systemic kinetics in humans. Unlike radioactive tracers, the 13C5 label is a stable isotope, making it safe for use in sensitive populations such as children and pregnant women. In clinical studies, such as those investigating colonic folate absorption, it allows researchers to differentiate between administered folate and endogenous folate pools by measuring the enrichment of the labeled compound in the systemic circulation using mass spectrometry. It functions biologically as a substrate for folate transport systems, including the reduced folate carrier and the proton-coupled folate transporter.

Other names
[13C5]-calcium-L-leucovorin[13C5]-folinic acid13C5-labeled leucovorincalcium L-5-formyltetrahydrofolate [13C5]
02

Targets

SLC46A1 (Proton-coupled folate transporter)RFC1 (Reduced folate carrier type 1)

Beyond the preview

Go deeper on 13C5-calcium-L-leucovorin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 13C5-calcium-L-leucovorin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call